We are live on ! Find out more
VIR icon

Vir Biotechnology
VIR

231 hedge funds and large institutions have $2.06B invested in Vir Biotechnology in 2023 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 83 increasing their positions, 75 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more call options, than puts

Call options by funds: $11M | Put options by funds: $6.98M

35% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 26

11% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 75

3% more funds holding

Funds holding: 224 → 231 (+7)

1.58% more ownership

Funds ownership: 64.66% → 66.24% (+1.6%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

6% less capital invested

Capital invested by funds: $2.18B → $2.06B (-$120M)

Holders
231
Holders Change
+7
Holders Change %
+3.13%
% of All Funds
3.68%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
35
Increased
83
Reduced
75
Closed
26
Calls
$11M
Puts
$6.98M
Net Calls
+$4.06M
Net Calls Change
+$1.52M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$43M
2
APM
Avidity Partners Management
Texas
+$20.2M
3
SI
Sofinnova Investments
California
+$16.8M
4
B
Braidwell
Connecticut
+$15.4M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$10.3M

Top Sellers

1
SIAU
SB Investment Advisers (UK)
United Kingdom
-$49.6M
2
Pacer Advisors
Pacer Advisors
Pennsylvania
-$28.1M
3
Morgan Stanley
Morgan Stanley
New York
-$14.8M
4
Capital Fund Management (CFM)
Capital Fund Management (CFM)
France
-$5.76M
5
Goldman Sachs
Goldman Sachs
New York
-$5.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
TPSF
76
Texas Permanent School Fund
Texas
$1.58M +$436K +17,035 +33%
State of Wisconsin Investment Board
77
State of Wisconsin Investment Board
Wisconsin
$1.57M -$144K -5,619 -8%
D.E. Shaw & Co
78
D.E. Shaw & Co
New York
$1.57M +$570K +22,305 +50%
Massachusetts Financial Services
79
Massachusetts Financial Services
Massachusetts
$1.56M -$1.02M -39,948 -37%
LSA
80
Leonteq Securities AG
Switzerland
$1.49M +$1.6M +62,372 +4,158%
EGM
81
Engineers Gate Manager
New York
$1.45M +$1.12M +43,642 +232%
DA
82
DCF Advisers
Connecticut
$1.44M +$972K +38,000 +158%
JFG
83
Jefferies Financial Group
New York
$1.41M +$1.55M +60,500 New
PA
84
Profund Advisors
Maryland
$1.38M +$1.17M +45,932 +349%
Millennium Management
85
Millennium Management
New York
$1.34M +$301K +11,760 +26%
CGL
86
Clarius Group LLC
Washington
$1.33M – – –
GC
87
Guggenheim Capital
Illinois
$1.22M +$885K +34,592 +195%
SOADOR
88
State of Alaska Department of Revenue
Alaska
$1.21M -$22.4K -875 -2%
RA
89
Royce & Associates
New York
$1.19M -$143K -5,596 -10%
Mirae Asset Global Investments
90
Mirae Asset Global Investments
South Korea
$1.15M +$267K +10,439 +27%
DA
91
Duality Advisers
Florida
$1.14M -$183K -7,157 -13%
State of Tennessee, Department of Treasury
92
State of Tennessee, Department of Treasury
Tennessee
$1.05M -$223K -8,705 -16%
Envestnet Asset Management
93
Envestnet Asset Management
Illinois
$1.05M +$7.53M +294,390 +589%
Dimensional Fund Advisors
94
Dimensional Fund Advisors
Texas
$1.05M – – –
VRS
95
Virginia Retirement Systems
Virginia
$1M +$476K +18,600 +76%
DekaBank Deutsche Girozentrale
96
DekaBank Deutsche Girozentrale
Germany
$991K – – –
YCM
97
Yousif Capital Management
Michigan
$990K -$233K -9,105 -18%
Two Sigma Investments
98
Two Sigma Investments
New York
$954K +$570K +22,287 +119%
AIG
99
American International Group
New York
$926K +$3.86K +151 +0.4%
Mercer Global Advisors
100
Mercer Global Advisors
Colorado
$924K +$98.9K +3,865 +11%
2 3
4
5 6

VIR Hedge Fund Activity: Q1 2023 in Review

231 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Vir Biotechnology (VIR) for Q1 2023, worth a combined $2.06B — down 5.5% from $2.18B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new VIR positions and 26 closed out — a net gain of 9 holders — while 83 added to existing stakes and 75 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $43M. The largest seller was SB Investment Advisers (UK), cutting an estimated $49.6M.

  • 231 institutional investors held Vir Biotechnology (VIR) as of Q1 2023, up from 224 in Q4 2022.
  • Funds reported $2.06B of Vir Biotechnology stock for Q1 2023, down 5.5% quarter-over-quarter.
  • 35 funds opened new Vir Biotechnology positions in Q1 2023 and 26 closed out, a net change of +9 holders.
  • The largest Vir Biotechnology buyer in Q1 2023 was Point72 Asset Management, an estimated $43M added.
  • The largest Vir Biotechnology seller in Q1 2023 was SB Investment Advisers (UK), an estimated $49.6M sold.

Based on aggregated 13F filings for Q1 2023.